In Brief
This article was originally published in The Tan Sheet
Executive Summary
Guidance adds reasons for petition denial
You may also be interested in...
In Brief
Committee demands final sunscreen rule
NBTY Appoints GE Vet To Succeed CEO Rudolph
Newly private NBTY replaces long-time CEO Scott Rudolph with Jeffrey Nagel, a company outsider and supplement industry newcomer.
FDA Will Summarily Deny Petitions Submitted Solely To Block ANDA Approvals
Blocking generic competition by using citizen petitions to delay abbreviated new drug application approvals just got harder, under an FDA draft guidance released Jan. 16